Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul 26:27:1609859.
doi: 10.3389/pore.2021.1609859. eCollection 2021.

Clinicopathological and Molecular Characteristics of Colorectal Signet Ring Cell Carcinoma: A Review

Affiliations
Review

Clinicopathological and Molecular Characteristics of Colorectal Signet Ring Cell Carcinoma: A Review

Yang An et al. Pathol Oncol Res. .

Abstract

Colorectal signet ring cell carcinoma (SRCC) is a rare subtype of colorectal cancer (CRC) with unique characteristics. Due to the limited researches on it, a comprehensive and in-depth understanding of this subtype is still lacking. In this article, we summarize the clinicopathological features and molecular characteristics of colorectal SRCC based on a literature review. Clinically, SRCC has been associated with young age, proximal site preference, advanced tumor stage, high histological grade, high rate of lymph node involvement, frequent peritoneal metastasis, and a significantly poor prognosis. Regarding molecular characteristics, in SRCC, the mutation burden of the classic signaling pathways that include WNT/β-catenin, RAS/RAF/MAPK, and PI3K/AKT/mTOR signaling pathways are generally reduced. In contrast, some genes related to the "epithelial-mesenchymal transition (EMT) process" and the "stem cell properties", including RNF43, CDH1, and SMAD4, as well as the related TGF-β signaling pathway have been observed more frequently altered in SRCC than in conventional adenocarcinoma (AC). In many studies but not in others, SRCC showed a higher frequency of BRAF mutation, microsatellite instability-high (MSI-H) and CpG island methylator phenotype (CIMP) positive status compared to AC. It has been proposed that colorectal SRCC consists of two subtypes, in which the MSI+/CIMP+/BRAF +/CD3+/PD-L1+ hypermethylated genotype is more common in the proximal colon, and may represent the potential candidate for immunotherapy. Understanding the special molecular mechanisms related to the aggressive biology of SRCC is of great importance, which may provide a theoretical basis for the development of more targeted and effective treatments for this refractory disease.

Keywords: clinicopathology; colorectal cancer; molecular features; review; signet ring cell carcinoma.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Comparison of clinicopathological characteristics between SRCC and AC [–6,20,91]. The above endoscopic and CT images are selected by the authors from the clinical database of Peking Union Medical College Hospital. Related patients have provided written informed consents for publication of their clinical data. Adobe Illustrator CC 2018 was used to create the artwork.
FIGURE 2
FIGURE 2
Comparison of molecular features between SRCC and AC [,,,–60,72,75,93]. Adobe illustrator CC 2018 was used to create the artwork.

References

    1. Arnold M, Abnet CC, Neale RE, Vignat J, Giovannucci EL, McGlynn KA, et al. Global Burden of 5 Major Types of Gastrointestinal Cancer. Gastroenterology (2020) 159(1):335–49. 10.1053/j.gastro.2020.02.068 - DOI - PMC - PubMed
    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer J Clinicians (2018) 68(6):394–424. 10.3322/caac.21492 - DOI - PubMed
    1. Laufman H, Saphir O. Primary Linitis Plastica Type of Carcinoma of the colon. Arch Surg (1951) 62(1):79–91. 10.1001/archsurg.1951.01250030082009 - DOI - PubMed
    1. Shi T, Huang M, Han D, Tang X, Chen Y, Li Z, et al. Chemotherapy Is Associated with Increased Survival from Colorectal Signet Ring Cell Carcinoma with Distant Metastasis: A Surveillance, Epidemiology, and End Results Database Analysis. Cancer Med (2019) 8(4):1930–40. 10.1002/cam4.2054 - DOI - PMC - PubMed
    1. Hugen N, Verhoeven RH, Lemmens VE, van Aart CJ, Elferink MA, Radema SA, et al. Colorectal Signet-Ring Cell Carcinoma: Benefit from Adjuvant Chemotherapy but a Poor Prognostic Factor. Int J Cancer (2015) 136(2):333–9. 10.1002/ijc.28981 - DOI - PubMed

Substances